Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolus (EOLS) Shares Outstanding (Weighted Average) (2018 - 2025)

Evolus' Shares Outstanding (Weighted Average) history spans 8 years, with the latest figure at $64.5 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 3.95% year-over-year to $64.5 million; the TTM value through Dec 2025 reached $64.5 million, up 3.95%, while the annual FY2025 figure was $64.5 million, 3.95% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $64.5 million in Q4 2025 per EOLS's latest filing, roughly flat from $64.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $64.5 million in Q2 2025 to a low of $37.1 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $57.0 million, with a median of $56.8 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): soared 51.66% in 2021, then grew 1.1% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $49.8 million in 2021, then rose by 12.64% to $56.1 million in 2022, then grew by 1.52% to $56.9 million in 2023, then rose by 8.96% to $62.0 million in 2024, then increased by 3.95% to $64.5 million in 2025.
  • Per Business Quant, the three most recent readings for EOLS's Shares Outstanding (Weighted Average) are $64.5 million (Q4 2025), $64.3 million (Q3 2025), and $64.5 million (Q2 2025).